Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, will present at the following investor conferences:
| Event | Oppenheimer 34th Annual Healthcare Life Sciences Conference |
| Date | February 13, 2024 |
| Time | 10:00 AM ET |
| Location | Virtual |
| Webcast Link | /webcast/oppenheimer33/register.aspx?conf=oppenheimer33&page=nvct&url=https://wsw.com/webcast/oppenheimer33/nvct/2804822 |
| Event | 2024 NeauxCancer Oncology Conference |
| Date | March 1, 2024 |
| Time | 1:00 PM CST |
| Location | New Orleans, LA |
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates, NXP800 and NXP900. NXP800 is an oral small molecule currently in a Phase 1b clinical trial investigating the activity of NXP800 as a potential treatment for platinum resistant, ARID1a-mutated ovarian carcinoma. The U.S. Food and Drug Administration (“FDA”) granted Fast Track Designation to the NXP800 development program in platinum resistant, ARID1a-mutated ovarian carcinoma, and Orphan Drug Designation for the treatment of cholangiocarcinoma. NXP900 is a novel, small molecule SRC/YES1 kinase inhibitor. The NXP900 Phase 1a dose escalation study is ongoing.
Company Contact
Ron Bentsur
Chairman, Chief Executive Officer and President
201-614-3151
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Relations Contact
Christopher M. Calabrese
LifeSci Advisors
Tel: 917-680-5608
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$5.00 |
| Daily Change: | -0.28 -5.30 |
| Daily Volume: | 64,567 |
| Market Cap: | US$93.250M |
November 05, 2024 August 06, 2024 | |
Northstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...
CLICK TO LEARN MORE
GreenPower Motor designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo van, and a cab and chassis...
CLICK TO LEARN MORE
